Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds

Publikation: Beitrag in FachzeitschriftArtikelForschung

Autoren

Organisationseinheiten

Externe Organisationen

  • Ruhr-Universität Bochum
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)18-23
Seitenumfang6
FachzeitschriftNatural Product Reports
Jahrgang38
Ausgabenummer1
Frühes Online-Datum23 Juli 2020
PublikationsstatusVeröffentlicht - 2021

Abstract

Covering: up to the beginning of 2020Many natural substances have been transformed again and again with regard to their pharmaceutical-medical potential, including new members of a growing class of natural products, the flavaglines. Important representatives are rocaglamide and silvestrol, isolated from the Aglaia species, which are highlighted here. These products started as potential anti-tumor agents five decades ago and have recently proved to be very promising antiviral agents, especially against RNA viruses. Today they are discussed as potential starting compounds for developing drug candidates and therapeutics.

ASJC Scopus Sachgebiete

Zitieren

Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds. / Schulz, Göran; Victoria, Catherine; Kirschning, Andreas et al.
in: Natural Product Reports, Jahrgang 38, Nr. 1, 2021, S. 18-23.

Publikation: Beitrag in FachzeitschriftArtikelForschung

Schulz G, Victoria C, Kirschning A, Steinmann E. Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds. Natural Product Reports. 2021;38(1):18-23. Epub 2020 Jul 23. doi: 10.1039/d0np00024h
Schulz, Göran ; Victoria, Catherine ; Kirschning, Andreas et al. / Rocaglamide and silvestrol : a long story from anti-tumor to anti-coronavirus compounds. in: Natural Product Reports. 2021 ; Jahrgang 38, Nr. 1. S. 18-23.
Download
@article{a79299b5225b485a95007903f1b61c0e,
title = "Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds",
abstract = "Covering: up to the beginning of 2020Many natural substances have been transformed again and again with regard to their pharmaceutical-medical potential, including new members of a growing class of natural products, the flavaglines. Important representatives are rocaglamide and silvestrol, isolated from the Aglaia species, which are highlighted here. These products started as potential anti-tumor agents five decades ago and have recently proved to be very promising antiviral agents, especially against RNA viruses. Today they are discussed as potential starting compounds for developing drug candidates and therapeutics.",
author = "G{\"o}ran Schulz and Catherine Victoria and Andreas Kirschning and Eike Steinmann",
year = "2021",
doi = "10.1039/d0np00024h",
language = "English",
volume = "38",
pages = "18--23",
journal = "Natural Product Reports",
issn = "0265-0568",
publisher = "Royal Society of Chemistry",
number = "1",

}

Download

TY - JOUR

T1 - Rocaglamide and silvestrol

T2 - a long story from anti-tumor to anti-coronavirus compounds

AU - Schulz, Göran

AU - Victoria, Catherine

AU - Kirschning, Andreas

AU - Steinmann, Eike

PY - 2021

Y1 - 2021

N2 - Covering: up to the beginning of 2020Many natural substances have been transformed again and again with regard to their pharmaceutical-medical potential, including new members of a growing class of natural products, the flavaglines. Important representatives are rocaglamide and silvestrol, isolated from the Aglaia species, which are highlighted here. These products started as potential anti-tumor agents five decades ago and have recently proved to be very promising antiviral agents, especially against RNA viruses. Today they are discussed as potential starting compounds for developing drug candidates and therapeutics.

AB - Covering: up to the beginning of 2020Many natural substances have been transformed again and again with regard to their pharmaceutical-medical potential, including new members of a growing class of natural products, the flavaglines. Important representatives are rocaglamide and silvestrol, isolated from the Aglaia species, which are highlighted here. These products started as potential anti-tumor agents five decades ago and have recently proved to be very promising antiviral agents, especially against RNA viruses. Today they are discussed as potential starting compounds for developing drug candidates and therapeutics.

UR - http://www.scopus.com/inward/record.url?scp=85101029616&partnerID=8YFLogxK

U2 - 10.1039/d0np00024h

DO - 10.1039/d0np00024h

M3 - Article

C2 - 32699874

VL - 38

SP - 18

EP - 23

JO - Natural Product Reports

JF - Natural Product Reports

SN - 0265-0568

IS - 1

ER -

Von denselben Autoren